EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Serum mediated immunosuppression in visceral leishmaniasis



Serum mediated immunosuppression in visceral leishmaniasis



Revista da Sociedade Brasileira de Medicina Tropical 22(2): 109-110



The mechanisms which mediate the suppressive activity of sera in visceral leishmaniasis were evaluated. The role of IgG as a suppressive element was also investigated. Sera were obtained from 19 clinically and parasitologically confirmed visceral leishmaniasis patients and from normal volunteers with no history or laboratory findings of visceral leishmaniasis.

(PDF 0-2 workdays service: $29.90)

Accession: 002219824

Download citation: RISBibTeXText



Related references

Serum-mediated immunosuppression in American visceral leishmaniasis. Memorias do Instituto Oswaldo Cruz 83 Suppl 1: 514-516, 1988

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. Journal of Clinical Investigation 83(3): 860-864, 1989

Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infection and Immunity 33(2): 498-500, 1981

Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression. Infection and Immunity 50(1): 169-174, 1985

Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients. Ethiopian Medical Journal 49(3): 179-186, 2011

Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. Journal of Immunology 147(1): 281-284, 1991

Visceral leishmaniasis and immunosuppression. Annales de Medecine Interne 142(3): 215-217, 1991

Serum mediated suppression in human visceral leishmaniasis role of igg and soluble interleukin 2 receptor. FASEB Journal 5(5): A1365, 1991

Immunosuppression in Kenyan visceral leishmaniasis. Clinical and Experimental Immunology 51(2): 207-214, 1983

Immunosuppression in experimental visceral leishmaniasis. Dissertation Abstracts International B, Sciences and Engineering 46(3): 788-789, 1985

Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunology (Oxford) 7(4): 439-450, 1985

Immunity and immunosuppression in experimental visceral leishmaniasis. Brazilian Journal of Medical and Biological Research 37(4): 615-623, 2004

Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations. International Journal of Dermatology 46(12): 1326-1326, 2008

Dynamics of immunosuppression in hamsters with experimental visceral leishmaniasis. Brazilian Journal of Medical and Biological Research 44(7): 666-670, 2012

Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infection and Immunity 66(3): 1233-1236, 1998